Reaction
Cystic Fibrosis Respiratory Infection Suppression reporting signals
As of the last recalculation, Cystic Fibrosis Respiratory Infection Suppression appears in 888 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is DORNASE ALFA (PRR 568.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dornase Alfa | 310 | 568.8 | 578.0 |
| Lumacaftor And Ivacaftor | 162 | 541.7 | 552.2 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 119 | 258.1 | 260.6 |
| Ivacaftor | 73 | 234.6 | 236.8 |
| Tobramycin Solution | 90 | 195.3 | 196.8 |
| Tobramycin Sulfate | 90 | 189.5 | 190.9 |
| Tobramycin | 158 | 187.1 | 188.3 |
| Pancrelipase | 177 | 134.0 | 134.6 |
| Ursosiol | 42 | 53.1 | 53.2 |
| Ursodiol | 42 | 47.4 | 47.5 |
| Sodium Chloride Tablet | 118 | 43.2 | 43.3 |
| Sodium Chloride Tablets | 118 | 43.2 | 43.3 |
| Phytonadione | 15 | 42.1 | 42.2 |
| Sodium Chloride | 119 | 40.6 | 40.7 |
| Minocycline | 19 | 39.0 | 39.1 |
| Oseltamivir | 7 | 20.8 | 20.8 |
| Azithromycin | 34 | 20.6 | 20.6 |
| Azithromycin Monohydrate | 34 | 19.9 | 19.9 |
| Fluticasone Propionate And Salmeterol Xinafoate | 48 | 19.7 | 19.8 |
| Fluticasone Propionate | 82 | 16.2 | 16.2 |
| Loratadine Oral | 30 | 14.8 | 14.8 |
| Montelukast | 50 | 14.7 | 14.7 |
| Amphetamine | 5 | 14.2 | 14.2 |
| Guanfacine | 4 | 12.0 | 12.0 |
| Mometasone Furoate And Formoterol Fumarate Dihydrate | 5 | 7.6 | 7.6 |